CompletedNot Applicable

Inflammatory Biomarkers for the Diagnosis of oPRES

China621 participantsStarted 2022-07-01

Plain-language summary

The purpose of this study is to explore the inflammatory biomarkers for the diagnosis of obstetric posterior reversible encephalopathy syndrome.

Who can participate

Age range16 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Pregnant women were diagnosed of PE or E.
✓. All patients were examined the cranial imaging (MRI or CT), and imaging findings meeting the diagnostic criteria of PRES or normal.
✓. all patients provided written informed consent.

Exclusion criteria

✕. patients combined with other neurological disorders
✕. patients combined with mental illness

What they're measuring

inflammatory biomarkers

Timeframe: Inflammatory biomarkers were collected within 1 day after the onset of symptoms.

cranial Imaging

Timeframe: Cranial Imaging was examined within 3 days after the onset of symptoms, such as s headaches, visual changes, seizures, consciousness impairment.

Trial details

NCT IDNCT05433870

SponsorDunjin Chen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-07-31

View on ClinicalTrials.gov More Posterior Reversible Encephalopathy Syndrome trials